Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
about
Organic production enhances milk nutritional quality by shifting fatty acid composition: a United States-wide, 18-month studyNeuroinflammation and psychiatric illnessA review of anti-inflammatory agents for symptoms of schizophreniaEarly interventions to prevent psychosis: systematic review and meta-analysisGender and duration of untreated psychosis: a systematic review and meta-analysisCognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysisInflammatory cytokines and neurological and neurocognitive alterations in the course of schizophreniaEarly interventions for prodromal stage of psychosisSupplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature DataCelecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsCurrent understandings about cognition and the neurobiological correlates in schizophreniaDHA Effects in Brain Development and FunctionOmega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?Omega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviorsWorking with Asian American youth at clinical high risk for psychosis: a case illustrationEvolving the future: toward a science of intentional changeAt risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical riskInflammation and schizophreniaHow should we intervene in psychosis risk syndromes?Developmental mechanisms in the prodrome to psychosisPredicting the risk of psychosis onset: advances and prospectsPrenatal choline and the development of schizophreniaRole of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseasesDeciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imagingWhite matter development in the early stages of psychosis.Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementationFrom Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismAttachment, Neurobiology, and Mentalizing along the Psychosis ContinuumN-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for PsychopathologyPrader-Willi syndrome mental health research strategy workshop proceedings: the state of the science and future directionsPostmortem evidence of cerebral inflammation in schizophrenia: a systematic reviewNutritional interventions for the adjunctive treatment of schizophrenia: a brief reviewA review of the biologic and pharmacologic role of docosapentaenoic acid n-3Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacyOmega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysisLipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychoticsDocosahexaenoic acid (DHA): an ancient nutrient for the modern human brainNutritional Psychiatry: Where to Next?Schizophrenia.Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction
P2860
Q21132398-22B0A826-1785-4A15-880E-3CFC4B25A34FQ21245244-B5DF5B4F-465C-4715-903C-8EAEAEF130B5Q22241827-78EB25F4-A764-4318-A953-5B1AE4328213Q22242061-2932F43F-B0A5-4902-8B3D-9ECB224B0FCAQ22242298-84E0FD0D-91E7-43BE-B49A-F507676BA1F6Q22251382-E6AD3FA5-6CEA-4E55-B264-8538FF7DF029Q24630651-06FBF662-E412-4353-89F3-EC3B1884EB29Q26471731-FEFB3752-B71E-4A86-AE27-CE6CBF0E2708Q26740508-BCD4C7CE-E85E-42C9-B3DE-B59873636E11Q26741541-719ADEE7-9547-47AA-984F-4EFC620DF008Q26745793-3F079111-F9EA-4C20-9BE9-6C3A2DC39064Q26770284-E122B9C0-8D62-4136-A61E-79196234D022Q26782982-AC483871-7724-4B46-83E3-AF3CF25F1C0DQ26822591-B4443441-E023-4637-A4B3-9D3F5254575FQ26827530-F7D9792F-A445-43B4-9BDC-85EDD6BB07F8Q26864880-F05EA27D-1BBF-414F-A0A0-5A440234F223Q27002449-F237503E-C0C4-47A4-A69B-69C4BC1DFFA1Q27002489-38748056-D74F-4360-ACB7-F2F39184A450Q27008060-02166073-6198-4767-8B9D-CA1AA68936ECQ27009237-AEF10BBE-99BE-49E4-BD6F-BFE8A0EC3FB7Q27011694-2AB9BA9F-516A-43EC-8D1A-554A4611893BQ27022263-0FB5F91E-1AE9-4F49-9403-49975A48EFA8Q27024102-A692127B-AA82-47D9-A095-1A6A3249FF3DQ27027307-BC5128F8-9100-44C6-B7C7-8AFA321FE7F9Q27686764-5A1FBCAB-FC5B-427F-92EA-A62163F7899AQ28066354-1ACE5442-41B6-49A6-B5C4-787B199DC9CAQ28067617-D24747BA-E279-4176-A012-FC74C9E0469AQ28069770-3124AA35-BEC5-4504-BDDA-118F5DF27962Q28072641-5B4C0A69-92E7-4F8A-A962-FF3A0220953EQ28074923-E41F9F30-6A11-45C8-AA1D-483F75B48A2AQ28077391-5B89B5F1-265B-4486-9E1D-1D907935CA34Q28248117-494BB89E-ADE2-4F16-A771-6B2358FD72A7Q28248251-37909D38-03F2-43CB-A433-CD1EB05B326CQ28297813-99FF85CE-1069-47ED-B585-66204B34E45CQ28315392-D8C86ADF-B58B-4624-8CEE-CB69B4490A04Q28534822-614EF6C7-98EB-4D3B-A2FF-68D176509454Q28732836-B6503C84-D16A-49FD-ACC5-71B0756A317AQ30235538-7B8AF3F5-2C25-48BF-8464-44D39983B5BAQ30251961-7DCB6EA8-D65C-48BC-9046-64A1B7E99037Q30355617-0BF3DAF7-39D2-4E5A-9CCD-AD8DCDF76B95
P2860
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@ast
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@en
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@nl
type
label
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@ast
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@en
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@nl
prefLabel
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@ast
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@en
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@nl
P2093
P50
P921
P1433
P1476
Long-chain omega-3 fatty acids ...... zed, placebo-controlled trial.
@en
P2093
Claudia M Klier
G Paul Amminger
Gregor E Berger
Konstantinos Papageorgiou
Miriam R Schäfer
Patrick D McGorry
P304
P356
10.1001/ARCHGENPSYCHIATRY.2009.192
P407
P577
2010-02-01T00:00:00Z